期刊文献+

普通肝素钠和低分子肝素钠在血液透析中的抗凝效果观察 被引量:4

下载PDF
导出
摘要 目的:观察普通肝素钠(UFH)和低分子肝素钠(LMWH)在血液透析中的抗凝效果。方法:56例维持性血液透析患者在血液透析过程中分别应用UFH和LMWH抗凝,各观察1个月(即8次血液透析),每周透析2次,每次4 h,血流量200~250 ml/min,透析液流量500 ml/min,温度37℃。透析结束后用200 ml生理盐水回血,观察透析器和血路管的血液残留情况。结果:UFH组有10例患者每次血液透析结束回血后透析器存在不同程度的血液残留,其中4例透析器血液残留较严重,且动、静脉壶内也有凝血块。LMWH组仅1例在观察初期(第1周)有轻度血液残留,至第2周以后基本上无血液残留现象。结论:LMWH在血液透析过程中抗凝效果明显优于UFH。
出处 《护理实践与研究》 2012年第21期15-16,共2页 Nursing Practice and Research
  • 相关文献

参考文献5

二级参考文献19

  • 1丁苏青,胡艳芳,裴继云.血液透析中应用抗凝剂的探讨[J].中国血液净化,2002,1(2):26-28. 被引量:7
  • 2[1]Kwiterovich PJ.The antiatherogenic role of high-density lipoprotein cholesterol.Am J Cardiol,1998 (9A):13-21.
  • 3[2]Bergvist D.Low molecular weight heparins.J Intern Med,2001,230:57-62.
  • 4[3]Verzola A,Perini L,Gatto S,et ai.Gauses and risks of hyperlipidemia during dialysis and after renal transplantation.Recenti Prog Med,1998,89:590597.
  • 5[4]DurringtoPN.Secondayhyperlipidaemia.BrMedB ull,1999,46:1005-101.
  • 6Stenvinkel P.Low molecular weight heparin:Does it favourably affect lipidlevels?[J].Nephrol Dial Transplant,1995,10 (1):16-18.
  • 7Ibels LS,Reardon MF,Nestel PJ.Plasma postheparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients[J].J Lab Clin Med,1976,87(6):648-658.
  • 8Williams KJ,Petrie KA,Brocia RW,et al.Lipoprotein lipsemodulates net secretory output of apolipoprotein B in vitro.A possible pathophysiologic explanation for familial combined hyperlipidemia[J].J Clin Invest,1991,88(4):1300-1306.
  • 9Bagshaw SM,Laupland KB,Boiteau PJ,et al.ls regional citratesuperior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system[J].J Crit Care,2005,20:155-161.
  • 10Mckeage K,Plosker GL.Argatroban[J].Drugs,2001,61:515-522.

共引文献47

同被引文献29

  • 1丁秀和,丁春华,闫现花,吕凤菊,闵庆虹,刘海丽,郑明华.肝素钠尿激酶混合液在血液透析长期留置导管封管中的应用[J].中国误诊学杂志,2009,9(5):1028-1029. 被引量:5
  • 2苏庆玲.无肝素技术在血液透析治疗中的应用及护理[J].中国血液净化,2004,3(11):634-635. 被引量:15
  • 3谢小华.维持性血液透析患者静脉留置针的临床观察[J].中国实用护理杂志(下旬版),2005,21(2):36-37. 被引量:32
  • 4Rossignol P,Dorval M,Fay R,et al.Rationale and design of the Hep Zero study:a prospective,multicenter,international,open,randomized,controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane(Evodial)versus standard care:study protocol for a randomized controlled trial[J].Trials,2013,14:163.
  • 5Lameire N,Kellum J A.Contrast-induced acute kidney injury and renal support for acute kidney injury:a KDIGO summary(Part2)[J].Critical Care,2013,17(1):205.
  • 6Shen J I,Winkelmayer W C.Use and Safety of Unfractionated Heparin for Anticoagulation During Maintenance Hemodialysis.American journal of kidney diseases:the official journal of the National Kidney Foundation[J].2012,60(3):473.
  • 7Monagle P,Chan A K C,Goldenberg N A,et al.Antithrombotic Therapy in Neonates and Children:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141(2 Suppl):e737S.
  • 8Fran ois K,Wissing K M,Jacobs R.Avoidance of systemic anticoagulation during intermittent haemodialysis with heparingrafted polyacrilonitrile membrane and citrate-enriched dialysate:a retrospective cohort study[J].BMC Nephrology,2014,15:104.
  • 9Rhee C M,Unruh M,Chen J.Infrequent Dialysis:A New Paradigm for Hemodialysis Initiation[J].Seminars in dialysis,2013,26(6):10.
  • 10蒋蓉玮.低分子肝素钠在血液透析中的作用[J].中国医药导刊,2012,14(2):590-591.

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部